Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)

The benefits of treating several types of cancers using immunotherapy have recently been established. The overexpression of nucleolin (NCL) in a number of types of cancer provides an attractive antigen target for the development of novel anticancer immunotherapeutic treatments. NCL is a multifunctio...

Descripción completa

Detalles Bibliográficos
Autores principales: Thongchot, Suyanee, Aksonnam, Krittaya, Thuwajit, Peti, Yenchitsomanus, Pa-Thai, Thuwajit, Chanitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555485/
https://www.ncbi.nlm.nih.gov/pubmed/37477132
http://dx.doi.org/10.3892/ijmm.2023.5284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555485/
https://www.ncbi.nlm.nih.gov/pubmed/37477132
http://dx.doi.org/10.3892/ijmm.2023.5284

Ejemplares similares